Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010
Identifieur interne : 000086 ( PascalFrancis/Checkpoint ); précédent : 000085; suivant : 000087Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010
Auteurs : M. Biggerstaff [États-Unis] ; M. A. Jhung [États-Unis] ; C. Reed [États-Unis] ; S. Garg [États-Unis] ; L. Balluz [États-Unis] ; A. M. Fry [États-Unis] ; L. Finelli [États-Unis]Source :
- Epidemiology and infection [ 0950-2688 ] ; 2014.
Descripteurs français
- Pascal (Inist)
English descriptors
Abstract
We analysed a cross-sectional telephone survey of U.S. adults to assess the impact of selected characteristics on healthcare-seeking behaviours and treatment practices of people with influenza-like illness (ILI) from September 2009 to March 2010. Of 216431 respondents, 8.1% reported ILI. After adjusting for selected characteristics, respondents aged 18-64 years with the following factors were more likely to report ILI: a diagnosis of asthma [adjusted odds ratio (aOR) 1.88, 95% CI 1.67-2.13] or heart disease (aOR 1.41, 95% CI 1.17-1.70), being disabled (aOR 1.75, 95% CI 1.57-1.96), and reporting financial barriers to healthcare access (aOR 1.63, 95% CI 1.45-1.82). Similar associations were seen in respondents aged ≥ 65 years. Forty percent of respondents with ILI sought healthcare, and 14% who sought healthcare reported receiving influenza antiviral treatment. Treatment was not more frequent in patients with high-risk conditions, except those aged 18-64 years with heart disease (aOR 1.90, 95% CI 1.03-3.51). Of patients at high risk for influenza complications, self-reported ILI was greater but receipt of antiviral treatment was not, despite guidelines recommending their use in this population.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:14-0201568Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010</title>
<author><name sortKey="Biggerstaff, M" sort="Biggerstaff, M" uniqKey="Biggerstaff M" first="M." last="Biggerstaff">M. Biggerstaff</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jhung, M A" sort="Jhung, M A" uniqKey="Jhung M" first="M. A." last="Jhung">M. A. Jhung</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Reed, C" sort="Reed, C" uniqKey="Reed C" first="C." last="Reed">C. Reed</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Garg, S" sort="Garg, S" uniqKey="Garg S" first="S." last="Garg">S. Garg</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Epidemic Intelligence Service, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Balluz, L" sort="Balluz, L" uniqKey="Balluz L" first="L." last="Balluz">L. Balluz</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Division of Behavioral Surveillance, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fry, A M" sort="Fry, A M" uniqKey="Fry A" first="A. M." last="Fry">A. M. Fry</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Finelli, L" sort="Finelli, L" uniqKey="Finelli L" first="L." last="Finelli">L. Finelli</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">14-0201568</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0201568 INIST</idno>
<idno type="RBID">Pascal:14-0201568</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000055</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001D64</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000086</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000086</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010</title>
<author><name sortKey="Biggerstaff, M" sort="Biggerstaff, M" uniqKey="Biggerstaff M" first="M." last="Biggerstaff">M. Biggerstaff</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jhung, M A" sort="Jhung, M A" uniqKey="Jhung M" first="M. A." last="Jhung">M. A. Jhung</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Reed, C" sort="Reed, C" uniqKey="Reed C" first="C." last="Reed">C. Reed</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Garg, S" sort="Garg, S" uniqKey="Garg S" first="S." last="Garg">S. Garg</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Epidemic Intelligence Service, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Balluz, L" sort="Balluz, L" uniqKey="Balluz L" first="L." last="Balluz">L. Balluz</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Division of Behavioral Surveillance, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fry, A M" sort="Fry, A M" uniqKey="Fry A" first="A. M." last="Fry">A. M. Fry</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Finelli, L" sort="Finelli, L" uniqKey="Finelli L" first="L." last="Finelli">L. Finelli</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Epidemiology and infection</title>
<title level="j" type="abbreviated">Epidemiol. infect.</title>
<idno type="ISSN">0950-2688</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Epidemiology and infection</title>
<title level="j" type="abbreviated">Epidemiol. infect.</title>
<idno type="ISSN">0950-2688</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral</term>
<term>Epidemiology</term>
<term>Flulike syndrome</term>
<term>Influenzavirus A(H1N1)</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antiviral</term>
<term>Traitement</term>
<term>Epidémiologie</term>
<term>Syndrome pseudogrippal</term>
<term>Virus grippal A(H1N1)</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We analysed a cross-sectional telephone survey of U.S. adults to assess the impact of selected characteristics on healthcare-seeking behaviours and treatment practices of people with influenza-like illness (ILI) from September 2009 to March 2010. Of 216431 respondents, 8.1% reported ILI. After adjusting for selected characteristics, respondents aged 18-64 years with the following factors were more likely to report ILI: a diagnosis of asthma [adjusted odds ratio (aOR) 1.88, 95% CI 1.67-2.13] or heart disease (aOR 1.41, 95% CI 1.17-1.70), being disabled (aOR 1.75, 95% CI 1.57-1.96), and reporting financial barriers to healthcare access (aOR 1.63, 95% CI 1.45-1.82). Similar associations were seen in respondents aged ≥ 65 years. Forty percent of respondents with ILI sought healthcare, and 14% who sought healthcare reported receiving influenza antiviral treatment. Treatment was not more frequent in patients with high-risk conditions, except those aged 18-64 years with heart disease (aOR 1.90, 95% CI 1.03-3.51). Of patients at high risk for influenza complications, self-reported ILI was greater but receipt of antiviral treatment was not, despite guidelines recommending their use in this population.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0950-2688</s0>
</fA01>
<fA02 i1="01"><s0>EPINEU</s0>
</fA02>
<fA03 i2="1"><s0>Epidemiol. infect.</s0>
</fA03>
<fA05><s2>142</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>BIGGERSTAFF (M.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>JHUNG (M. A.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>REED (C.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>GARG (S.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BALLUZ (L.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>FRY (A. M.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>FINELLI (L.)</s1>
</fA11>
<fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Epidemic Intelligence Service, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Division of Behavioral Surveillance, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>114-125</s1>
</fA20>
<fA21><s1>2014</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>6056</s2>
<s5>354000501655550140</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2014 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>40 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>14-0201568</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Epidemiology and infection</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We analysed a cross-sectional telephone survey of U.S. adults to assess the impact of selected characteristics on healthcare-seeking behaviours and treatment practices of people with influenza-like illness (ILI) from September 2009 to March 2010. Of 216431 respondents, 8.1% reported ILI. After adjusting for selected characteristics, respondents aged 18-64 years with the following factors were more likely to report ILI: a diagnosis of asthma [adjusted odds ratio (aOR) 1.88, 95% CI 1.67-2.13] or heart disease (aOR 1.41, 95% CI 1.17-1.70), being disabled (aOR 1.75, 95% CI 1.57-1.96), and reporting financial barriers to healthcare access (aOR 1.63, 95% CI 1.45-1.82). Similar associations were seen in respondents aged ≥ 65 years. Forty percent of respondents with ILI sought healthcare, and 14% who sought healthcare reported receiving influenza antiviral treatment. Treatment was not more frequent in patients with high-risk conditions, except those aged 18-64 years with heart disease (aOR 1.90, 95% CI 1.03-3.51). Of patients at high risk for influenza complications, self-reported ILI was greater but receipt of antiviral treatment was not, despite guidelines recommending their use in this population.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Traitement</s0>
<s5>06</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Treatment</s0>
<s5>06</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Syndrome pseudogrippal</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Flulike syndrome</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Virus grippal A(H1N1)</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Influenzavirus A(H1N1)</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fN21><s1>251</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Géorgie (États-Unis)</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Biggerstaff, M" sort="Biggerstaff, M" uniqKey="Biggerstaff M" first="M." last="Biggerstaff">M. Biggerstaff</name>
</region>
<name sortKey="Balluz, L" sort="Balluz, L" uniqKey="Balluz L" first="L." last="Balluz">L. Balluz</name>
<name sortKey="Finelli, L" sort="Finelli, L" uniqKey="Finelli L" first="L." last="Finelli">L. Finelli</name>
<name sortKey="Fry, A M" sort="Fry, A M" uniqKey="Fry A" first="A. M." last="Fry">A. M. Fry</name>
<name sortKey="Garg, S" sort="Garg, S" uniqKey="Garg S" first="S." last="Garg">S. Garg</name>
<name sortKey="Garg, S" sort="Garg, S" uniqKey="Garg S" first="S." last="Garg">S. Garg</name>
<name sortKey="Jhung, M A" sort="Jhung, M A" uniqKey="Jhung M" first="M. A." last="Jhung">M. A. Jhung</name>
<name sortKey="Reed, C" sort="Reed, C" uniqKey="Reed C" first="C." last="Reed">C. Reed</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000086 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000086 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= PascalFrancis |étape= Checkpoint |type= RBID |clé= Pascal:14-0201568 |texte= Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010 }}
This area was generated with Dilib version V0.6.34. |